Span Divergent Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider and approve 1. To consider and approve ....
Awaiting price reaction for this filing.
Span Divergent Ltd (formerly Span Diagnostics Ltd) has informed BSE that its Board of Directors will meet on May 16, 2025 to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2025, along with the Auditor's Report and draft Directors' Report. The Board will also consider recommending a dividend (if any) for FY25, appoint the Secretarial Auditor and Statutory Auditor (subject to shareholder approval), and appoint an Internal Auditor for FY26. Additionally, the Board will finalise the date, time and venue of the 45th Annual General Meeting and approve the AGM notice. The trading window for insiders will remain closed till May 19, 2025.
This is a routine pre-results announcement — no financial numbers are disclosed yet. Shareholders should watch the May 16 meeting for actual Q4/FY25 results, dividend decision, and any change in auditors, which could be price-sensitive.